Oramed Pharmaceuticals Stock Market Value
| ORMP Stock | USD 3.41 0.17 5.25% |
| Symbol | Oramed |
Can Pharmaceuticals industry sustain growth momentum? Does Oramed have expansion opportunities? Factors like these will boost the valuation of Oramed Pharmaceuticals. Anticipated expansion of Oramed directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Oramed Pharmaceuticals demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.409 | Earnings Share 1 | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets |
Oramed Pharmaceuticals's market price often diverges from its book value, the accounting figure shown on Oramed's balance sheet. Smart investors calculate Oramed Pharmaceuticals' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Oramed Pharmaceuticals' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Oramed Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Oramed Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Oramed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oramed Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oramed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oramed Pharmaceuticals.
| 11/10/2025 |
| 02/08/2026 |
If you would invest 0.00 in Oramed Pharmaceuticals on November 10, 2025 and sell it all today you would earn a total of 0.00 from holding Oramed Pharmaceuticals or generate 0.0% return on investment in Oramed Pharmaceuticals over 90 days. Oramed Pharmaceuticals is related to or competes with Ovid Therapeutics, Context Therapeutics, Clene, Shattuck Labs, Coya Therapeutics, MacroGenics, and ImageneBio. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of dia... More
Oramed Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oramed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oramed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.7 | |||
| Information Ratio | 0.1765 | |||
| Maximum Drawdown | 17.67 | |||
| Value At Risk | (3.76) | |||
| Potential Upside | 6.98 |
Oramed Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oramed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oramed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oramed Pharmaceuticals historical prices to predict the future Oramed Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1699 | |||
| Jensen Alpha | 0.5525 | |||
| Total Risk Alpha | 0.361 | |||
| Sortino Ratio | 0.237 | |||
| Treynor Ratio | 0.3433 |
Oramed Pharmaceuticals February 8, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1699 | |||
| Market Risk Adjusted Performance | 0.3533 | |||
| Mean Deviation | 2.8 | |||
| Semi Deviation | 2.06 | |||
| Downside Deviation | 2.7 | |||
| Coefficient Of Variation | 496.96 | |||
| Standard Deviation | 3.63 | |||
| Variance | 13.14 | |||
| Information Ratio | 0.1765 | |||
| Jensen Alpha | 0.5525 | |||
| Total Risk Alpha | 0.361 | |||
| Sortino Ratio | 0.237 | |||
| Treynor Ratio | 0.3433 | |||
| Maximum Drawdown | 17.67 | |||
| Value At Risk | (3.76) | |||
| Potential Upside | 6.98 | |||
| Downside Variance | 7.29 | |||
| Semi Variance | 4.25 | |||
| Expected Short fall | (3.86) | |||
| Skewness | 0.7356 | |||
| Kurtosis | 0.1358 |
Oramed Pharmaceuticals Backtested Returns
Oramed Pharmaceuticals appears to be unstable, given 3 months investment horizon. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.23, which implies the firm had a 0.23 % return per unit of risk over the last 3 months. By analyzing Oramed Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.83% is justified by implied risk. Please evaluate Oramed Pharmaceuticals' Semi Deviation of 2.06, risk adjusted performance of 0.1699, and Coefficient Of Variation of 496.96 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oramed Pharmaceuticals holds a performance score of 17. The company holds a Beta of 2.1, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oramed Pharmaceuticals will likely underperform. Please check Oramed Pharmaceuticals' standard deviation, expected short fall, period momentum indicator, as well as the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Oramed Pharmaceuticals' historical price patterns will revert.
Auto-correlation | 0.75 |
Good predictability
Oramed Pharmaceuticals has good predictability. Overlapping area represents the amount of predictability between Oramed Pharmaceuticals time series from 10th of November 2025 to 25th of December 2025 and 25th of December 2025 to 8th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oramed Pharmaceuticals price movement. The serial correlation of 0.75 indicates that around 75.0% of current Oramed Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Pair Trading with Oramed Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oramed Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Oramed Stock
| 0.89 | JNJ | Johnson Johnson | PairCorr |
| 0.69 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.89 | LPCN | Lipocine | PairCorr |
Moving against Oramed Stock
| 0.85 | HPQ | HP Inc | PairCorr |
| 0.74 | MSFT | Microsoft | PairCorr |
| 0.43 | BRK-A | Berkshire Hathaway | PairCorr |
| 0.35 | MMM | 3M Company | PairCorr |
| 0.32 | VLCN | Volcon Inc Symbol Change | PairCorr |
The ability to find closely correlated positions to Oramed Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oramed Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oramed Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oramed Pharmaceuticals to buy it.
The correlation of Oramed Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oramed Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oramed Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oramed Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Oramed Stock Analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.